Mass screening for breast cancer
Cottu, P.-H.; Cuvier, C.; Perret, F.; Gorins, A.é; Espié, M.
Presse Medicale 32(3): 120-124
2003
ISSN/ISBN: 0755-4982 PMID: 12610384 Document Number: 566610
A CONTROVERSIAL SUBJECT: Several large randomised studies have demonstrated a reduction in mortality due to breast cancer of around 30% in women aged over 50, with the development of systematic mammography. There are data also suggesting an identical benefit in women aged 40 to 49, when screening is intensified. A recent meta-analysis has contradicted the results of randomised studies on screening, but this study is clearly debatable. THE SITUATION IN FRANCE: No randomised study has been organised. A national program is aimed at screening 7 400 000 women aged 50 to 74. THE KEY TO SUCCESS: The active participation of women, health professionals and public authorities is the fundamental condition for a well-organised mass screening.